article · Annals of Clinical and Translational Neurology · 2021

The Multiple Sclerosis Treatment Optimization Program

Annette Langer‐Gould, Stephen C. Cheng, Bonnie H. Li, Michael H. Kanter

Cited by 12Open access

Abstract

The causes of wasteful spending on MS DMTs are complex and require multiple strategies to resolve. We provide herein granular details of how we designed and implemented our health system intervention to facilitate its adaption to other settings and conditions.

Cite this paper

APA 7

Langer‐Gould, A., Cheng, S. C., Li, B. H., & Kanter, M. H. (2021). The Multiple Sclerosis Treatment Optimization Program. Annals of Clinical and Translational Neurology, 8(11), 2146–2154. https://doi.org/10.1002/acn3.51472

MLA 9

Langer‐Gould, Annette, et al. “The Multiple Sclerosis Treatment Optimization Program.” Annals of Clinical and Translational Neurology, vol. 8, no. 11, 2021, pp. 2146–54, https://doi.org/10.1002/acn3.51472.

Chicago

Langer‐Gould, Annette, Stephen C. Cheng, Bonnie H. Li, and Michael H. Kanter. 2021. “The Multiple Sclerosis Treatment Optimization Program.” Annals of Clinical and Translational Neurology 8 (11): 2146–54. https://doi.org/10.1002/acn3.51472.

Harvard

Langer‐Gould, A. et al. (2021) ‘The Multiple Sclerosis Treatment Optimization Program’, Annals of Clinical and Translational Neurology, 8(11), pp. 2146–2154. Available at: https://doi.org/10.1002/acn3.51472.

BibTeX

@article{langergould2021multiple,
  title = {{The Multiple Sclerosis Treatment Optimization Program}},
  author = {Langer‐Gould, Annette and Cheng, Stephen C. and Li, Bonnie H. and Kanter, Michael H.},
  journal = {Annals of Clinical and Translational Neurology},
  volume = {8},
  number = {11},
  pages = {2146--2154},
  year = {2021},
  doi = {10.1002/acn3.51472}
}

Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.